We strive to develop and provide a stable supply of innovative, science-based pharmaceuticals.
To Increase Product Reliability
A Global-Standard Regulatory Compliance and Quality Assurance System
Chugai Group works hard to supply high-quality medicines and pharmaceuticals, and to ensure patients and healthcare providers use its products properly by offering timely and accurate delivery of quality information.
Policy for Regulatory Compliance and Quality Assurance
Chugai’s basic approach is set forth in the policy for regulatory compliance and quality assurance.
The policy for regulatory compliance and quality assurance places specific emphasis on the following four points (four qualities).
- Product quality
- Product information quality
- Business process quality
- Staff suitability
To provide high-quality products and information, Chugai believes it is important to ensure the quality of the business processes that generate them, and to secure suitable personnel to actually perform that work.
System for Ensuring Reliability in the Product Lifecycle
To provide patients and healthcare workers with products of superior efficacy and safety, Chugai engages in a continuous effort to ensure reliability across the product lifecycle, from R&D to application for approval, manufacturing and marketing, and approval withdrawal.
System for ensuring reliability in the product lifecycle
Handling of Inquiries by the Medical Information Department
Advances in scientific technology in recent years have seen the development of many innovative drugs and treatment methods, but at the same time, treatments have grown more sophisticated and complex, and there is a need to offer the right patients the appropriate therapies at the appropriate time. To achieve these goals, it is important that both healthcare providers and patients themselves actively participate in treatment, and pharmaceutical companies are increasingly required to provide more detailed information in lay terms on product quality, effectiveness and safety to ensure that drugs are used appropriately.
Chugai’s Medical Information Dept. responds to inquiries from patients, their families and healthcare providers via telephone, our website, e-mail and other diverse channels. Taking advantage of the benefits of being a member of the Roche Group, it provides information that is both highly specialized and globally consistent.
Medical Information Dept. received approximately 60,000 inquiries in 2017, on par with the previous year. About 75 percent of the inquiries came from pharmacists in hospitals or community pharmacies. By drug category, anti-influenza agents accounted for about 21 percent of all inquiries. The center also received many inquiries concerning anticancer agents, osteoporosis treatments, humanized anti-human IL-6 receptor monoclonal antibody for treatment, and long-acting erythropoietin-stimulating agents.
The staff at the center will continue working together to enhance customer satisfaction with a patient-oriented philosophy.
Number of Inquiries Received
Inquiries by Treatment Area (2017)
Contributing to Patient-Centered Healthcare
Conducting Support Activities for Patients
Relay for Life Japan
Relay for Life Japan (RFLJ) is an awareness support campaign that forges ties in the fight against cancer, the highlight of which is a 24-hour walk-a-thon in which cancer patients, their families and supporters compete as relay teams. The event aspires to celebrate the lives of cancer survivors, honor the memories of loved ones who have died, and stand up in the fight to conquer cancer by educating the public about prevention and exams. In 2017, the event was held in 49 locations throughout Japan. Chugai employees have participated as volunteers in the RFLJ since 2007, and in 2017, a total of 490 employees participated in “Team Chugai” at 29 locations nationwide. A total of 1,499 took part in an augmented reality experience exploring seven secrets of the stomach, offered at 23 venues as part of our disease awareness activities. As “Team Chugai” members described the display, participants looked into their viewers to learn about phenomena related to stomach cancer, gaining an understanding of the importance of early discovery and treatment of stomach cancer.
Supporting Patients with Infantile Lymphangioma
For 27 years, Chugai has worked to provide an agent for treating lymphangiomas*1 free of charge to children around the world suffering from this rare disease. To date, Chugai has provided this drug in over 80 countries around the world.
- *1 A rare disease in which lymphatic fluid abnormally pools in the lymphatic vessels. In many, cases it is found at birth. Unlike cancer, lymphatic formations are benign but can retard a child’s development, and occasionally the cysts compress the respiratory tract and become life-threatening.